The combination of p53 mutation and neu/erbB-2 amplification is associated with poor survival in node-negative breast cancer (Q75216726)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 January 2004
edit
Language Label Description Also known as
English
The combination of p53 mutation and neu/erbB-2 amplification is associated with poor survival in node-negative breast cancer
scientific article published on 01 January 2004

    Statements

    The combination of p53 mutation and neu/erbB-2 amplification is associated with poor survival in node-negative breast cancer (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit